EULAV Asset Management - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 27 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
EULAV Asset Management ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$304,000
-26.4%
123,0000.0%0.02%
-27.3%
Q3 2014$413,000
+25.5%
123,0000.0%0.02%
+22.2%
Q2 2014$329,000
+19.2%
123,0000.0%0.02%
+20.0%
Q1 2014$276,000
+14.0%
123,0000.0%0.02%
+15.4%
Q4 2013$242,000123,0000.01%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Baker Brothers Advisors 219,440,000$335,332,0004.77%
Sage Capital Management, LLC 1,500,000$2,290,0002.19%
SYMPHONY ASSET MANAGEMENT LLC 12,727,000$19,448,0001.97%
DINSMORE CAPITAL MANAGEMENT CO/NJ 1,200,000$1,840,0000.77%
Nicholas Investment Partners, LP 5,000,000$7,641,0000.64%
AVIVA PLC 25,000,000$38,328,0000.34%
PRUDENTIAL PLC 38,326,000$58,566,0000.15%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 8,000,000$12,225,0000.13%
FRANKLIN RESOURCES INC 17,290,000$26,432,0000.01%
LORD, ABBETT & CO. LLC 3,191,000$4,892,0000.01%
View complete list of SALIX PHARMACEUTICALS INC shareholders